The use of insulin pumps in the management of patients with type 1 diabetes is associated, compared to the administration of multiple daily insulin injections, with a reduction of up to 29% of mortality due to any cause and with a decrease in the44% of the risk of fatal cardiovascular disease - coronary disease or stroke.
This is shown by a study carried out by researchers from the University of Gothenburg (Sweden) and presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) held in Vienna (Austria).
In the words of Dr. Soffia Gudbjörnsdottir, director of the research, "the conclusion of this great observational study is that treatment with insulin pumps may be associated with a lower risk of cardiovascular diseases and mortality for any cause compared to injections".
Less mortality
To carry out the study, the researchers evaluated for an average period of 7 years to a total of 18,168 patients with type 1 diabetes included in the National Registry of Diabetes of Sweden.In total, the number of participants treated with insulin bombs was 2,441 - in front of 15,727 who received multiple daily insulin injections.
The results did not show significant differences between both groups of patients in terms of the risk of developing fatal or non -fatal cardiovascular disease.Differences that, however, were observed when both total mortality - 7% in the case of injections against 3% in insulin pumps - and fatal ECV - 3% against1%.
In addition, the results were not affected by variables such as the type of care, the patient's diabetological education, the use of continuous glucose monitoring or adhesion to treatments.
